| Date | Form | Description | Docs | XBRL | Pages |
| 05/08/24 | 8-K | Current report filing |
|
|
3 |
| 05/03/24 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 05/02/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/10/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/22/24 | 8-K | Current report filing |
|
|
36 |
| 03/15/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/15/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 02/08/24 | DEF 14A | Definitive proxy statements |
|
19 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
Read More...Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Read More...